For instance, a meta-analysis by Brandner et al. [73] confirmed that methylated MGMT is linked to better clinical outcomes across various studies, asserting that MGMT promoter methylation influences both the efficacy of chemotherapy and the overall survival of GBM patients. Here, MGMT is linked to glioblastoma.